Company Active LTD

Company profile

Psyomics Ltd

UK company 09470381, incorporated on 4 March 2015.

Psyomics

Our technology gets to the root of mental health, helping more people find the best support for their needs, whenever they need it.

Company number
09470381
Incorporated
4 Mar 2015
Companies House status
Active

Company identity

Founded / incorporated
4 March 2015

Company number 09470381

Verify at Companies House
Legal name
PSYOMICS LTD
Company type
LTD
Region
East of England
Registered address
Unknown
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

2 levels 1 ultimate controller
1
Company Active LTD
Psyomics Ltd
CRN 09470381
2
Direct controller Active LTD
Parkwalk Advisors Ltd
CRN 06925696
3
Ultimate controller Active PLC
Ip Group PLC
CRN 04204490

Company events

Reference milestones and recent Companies House filing stream events.

5 events
04 Sep
2026

Memorandum Articles

Incorporation

MA | Transaction MzU0MDk3Mzk2OWFkaXF6a2N4 | Paper/PDF filed

Published 08 Sep 2026 03:36

04 Sep
2026

Resolution

Resolution

RESOLUTIONS | Transaction WUY5QUtPSEVhZGlxemtjeA | Paper/PDF filed

Published 08 Sep 2026 03:25

26 Aug
2026

Capital Allotment Shares

Capital

SH01 | Transaction MzU0MDk3MjgyN2FkaXF6a2N4

Published 26 Aug 2026 07:26

12 Aug
2026

Appoint Person Director Company With Name Date

Officers

AP01 | Transaction MzUzODI2ODAxNmFkaXF6a2N4

Published 12 Aug 2026 08:58

04 Mar
2015

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2016
Funded years
2016, 2017, 2026
Age at first award
1 years

Projects

2026 Innovation Loans Lead participant

Scaling mental health care through intelligent clinical decision support tools

10 Jun 2026 to 10 Jun 2030

Awarded
£3,500,000
Total cost £4,730,621

Demand for mental-health treatment is rising sharply. Across UK NHS adult services, around 1.6 million people are currently on waiting lists, with some individuals facing delays of up to 800 days. For children and young people, the situation is similarly alarming, as of February 2025, almost 400,000 were waiting for care, the highest ever recorded. At the...

2017 Collaborative R&D Lead participant

Development of diagnostic device to differentiate between bipolar and unipolar depression

1 Nov 2017 to 30 Apr 2019

Awarded
£157,431
Total cost £224,902

Bipolar disorder affects 2.4m people in the UK alone and has an estimated prevalence of around 2% globally, yet 40% of patients with bipolar disorder are misdiagnosed with depression and it takes an average of 7.5 years for the correct diagnosis to be reached. This leads to ineffective treatments, increased suicide risk, antidepressant-induced mania and h...

2016 Procurement Lead participant

PsyOmics Quantified Health Solution

1 Apr 2016 to 31 Dec 2016

Awarded
£42,000
Total cost £42,000

PsyOmics Ltd is a biotech company that is working in collaboration with the Cambridge Centre for Neuropsychiatric Research (CCNR) to deliver improved prevention, diagnosis and treatment of psychiatric conditions. We aim to: (i) Improve treatment by providing contract research services to support clinical trials for psychiatric treatment (ii) Improve diagn...

Product types

Collaborative R&D Innovation Loans Procurement